Company Overview of Pique Therapeutics, Inc.
Pique Therapeutics, Inc., a biopharmaceutical company, develops therapeutic vaccines primarily for treating cancer. It develops products to treat non-small cell lung, colorectal, head and neck, and pancreatic cancers. The company was founded in 2005 and is based in Durham, North Carolina.
2530 Meridian Parkway
Durham, NC 27713
Founded in 2005
Key Executives for Pique Therapeutics, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Pique Therapeutics, Inc., please visit www.piquetherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.